Letters to the Editor

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database

University of Alberta, Edmonton, Alberta
Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON
Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON
Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Canadian Myeloma Research Group, Toronto, Ontario
The Ottawa Hospital, Ottawa, Ontario
Tom Baker Cancer Centre, Calgary, Alberta
Department of Oncology, Division of Hematology, McGill University, Montreal, QC
BC Cancer, Vancouver General Hospital, British Columbia
Queen Elizabeth II Health Sciences Centre. Dalhousie University, Halifax, Nova Scotia
Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan
Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec
Department of Oncology, Saint John Regional Hospital, Saint John, NB
Allan Blair Cancer Centre, Regina, Saskatchewan
London Regional Cancer Center, London, Ontario
Cancer Care Manitoba, Winnipeg, Manitoba
Canadian Myeloma Research Group, Toronto, Ontario
Canadian Myeloma Research Group, Toronto, Ontario
Cross Cancer Institute, University of Alberta, Edmonton, Alberta
Haematologica Early view Oct 13, 2020 https://doi.org/10.3324/haematol.2020.259093